Brimonidine Tartrate CAS 70359-46-5 Assay 99.0% ~ 101.0%
Shanghai Ruifu Chemical Co., Ltd bụ onye na-emepụta Brimonidine Tartrate (CAS: 70359-46-5) nwere oke mma.Nhọrọ α2-adrenergic agonist receptor, ọgwụ eji agwọ glaucoma mepere emepe ma ọ bụ ọbara mgbali anya.Ruifu Chemical nwere ike ịnye nnyefe zuru ụwa ọnụ, ọnụahịa asọmpi, ọrụ magburu onwe ya, obere na nnukwu ọnụọgụ dị.Ịzụta Brimonidine Tartrate,Please contact: alvin@ruifuchem.com
| Aha Chemical | Brimonidine Tartrate |
| Ụdị okwu | Brimonidine L-Tartrate;UK 14304 Tartrate;AGN190342 Tartrate;5-Bromo-N- (4,5-Dihydro-1H-Imidazol-2-yl) quinoxalin-6-Amine Tartrate;5-Bromo-N- (4,5-Dihydro-1H-Imidazol-2-yl) -6-Quinoxalinamine Tartrate;5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)quinoxalin-6-Amine (2R,3R) -2,3-Dihydroxysuccinate |
| Ọnọdụ Ahịa | Na ngwaahịa, Mmepụta Azụmahịa |
| Nọmba CAS | 70359-46-5 |
| Usoro ihe omimi | C11H10BrN5·C4H6O6 |
| Ibu molekụla | 442.23 g/mol |
| Ebe Na-agbaze | 207.0 ~ 208.0 ℃ (Dec.) |
| Mmetụta | Mmetụta ikuku, Mmetụta okpomọkụ |
| COA & MSDS | Dị |
| Mmalite | Shanghai, China |
| Ndụ shelf | Ọnwa 24 ma ọ bụrụ na echekwara ya nke ọma |
| Otu | API (Egwuregwu ọgwụ na-arụ ọrụ) |
| Ụdị | Ruifu Chemical |
| Ihe | Nkọwapụta | Nsonaazụ |
| Ọdịdị | Ọcha ma ọ bụ ntakịrị odo ma ọ bụ Ntụ ntụ Brown dị ntakịrị | Dabara |
| njirimara A | Ntụgharị ngwa anya akọwapụtara | Dabara |
| njirimara B | Spectrophotometry nke absorption infrared | Dabara |
| Solubility | Na-agbaze n'ime mmiri, ọ fọrọ nke nta ka ọ bụrụ ihe a na-adịghị ahụkebe na ethanol anhydrous yana na toluene | Dabara |
| Ntụgharị ngwa anya akọwapụtara | +9.0° ~ +10.5° | +9.6° |
| Ọnwụ na ihicha | ≤0.50% | 0.20% |
| Sulfated Ash | ≤0.20% | 0.07% |
| Ọla dị arọ | ≤20ppm | <20ppm |
| Ihe ndị emetụtara | ||
| Ihe adịghị ọcha akọwapụtara | ||
| N-(imidazolidin2ylidene) quinoxalin-6-amine | ≤0.10% | Dabara |
| 5-bromoqulinoxalin-6-amine | ≤0.10% | Dabara |
| Quinoxalin-6-amine | ≤0.10% | Dabara |
| 1- (5-bromoquinoxalin-6-yl) thiourea | ≤0.10% | Dabara |
| 2- (5-bromoquinoxalin-6-yl) guanidine | ≤0.10% | Dabara |
| 5-bromo-N-(1H-imidazole-2-yl)Quinoxalin-6-amine | ≤0.10% | Dabara |
| 1- (2-aminoethyl) -3- (5-bromoquinoxalin-6-yl) urea | ≤0.10% | Dabara |
| Ihe adịghị akọwapụtaghị | ≤0.10% | Dabara |
| Mkpokọta | ≤0.20% | 0.12% |
| Nyocha | 99.0% ~ 101.0% (na akpọnwụwo) | 99.8% |
| Mmechi | Ngwaahịa a site na nlebanya kwekọrọ na ọkọlọtọ BP2015 | |
ngwugwu:Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Debe akpa ahụ nke ọma ma chekwaa n'ebe dị jụụ, kpọrọ nkụ (2 ~ 8 ℃) yana ụlọ nkwakọba ihe nke ọma na-esi na ihe ndị na-adabaghị adaba.Zere ikpughe ìhè anyanwụ kpọmkwem, iru mmiri na oke okpomọkụ.
Mbupu:Jiri ikuku na-ebuga ụwa niile site na FedEx / DHL Express.Nye nnyefe ngwa ngwa na ntụkwasị obi.
Kedu ka esi azụta?Biko kpọtụrụDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Ahụmịhe afọ 15?Anyị nwere ihe karịrị 15 afọ nke ahụmahụ na mmepụta na mbupụ nke a dịgasị iche iche nke elu mma pharmaceutical intermediates ma ọ bụ ezi kemịkal.
Isi ahịa?Na-ere ahịa ụlọ, North America, Europe, India, Korea, Japanese, Australia, wdg.
Uru?Ogo kachasị elu, ọnụ ahịa dị ọnụ ala, ọrụ ọkachamara na nkwado teknụzụ, nnyefe ngwa ngwa.
OgoNkwenye?Usoro njikwa mma siri ike.Ngwá ọrụ ọkachamara maka nyocha gụnyere NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, wdg.
Ihe atụ?Ọtụtụ ngwaahịa na-enye ihe nlele efu maka nyocha dị mma, ndị ahịa kwesịrị ịkwụ ụgwọ mbupu.
Nyocha ụlọ ọrụ?Nnabata nyocha ụlọ ọrụ.Biko mee oge oge tupu oge eruo.
MOQ?Enweghị MOQ.A na-anabata obere usoro.
Oge Mbuga ozi? Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ.
Ụgbọ njem?Site Express (FedEx, DHL), nke ikuku, site n'oké osimiri.
Akwụkwọ?Mgbe ọrụ ahịa gasịrị: COA, MOA, ROS, MSDS, wdg nwere ike ịnye.
Synthesis omenala?Nwere ike ịnye ọrụ nhazi ahaziri iche ka ọ dabara mkpa nyocha gị nke ọma.
Usoro ịkwụ ụgwọ?A ga-ebu ụzọ ziga akwụkwọ ọnụahịa Proforma mgbe nkwenye nke iwu, kpuchiri ozi ụlọ akụ anyị.Ịkwụ ụgwọ site na T/T (Telex Nyefee), PayPal, Western Union, wdg.
Okwu egwu H301: Na-egbu egbu ma ọ bụrụ na iloro ya.
Okwu ịkpachapụ anya
P501: Tụfuo ọdịnaya/akpa n'ụlọ ọrụ mkpofu akwadoro.
P270: erila, aṅụ ma ọ bụ anwụrụ ọkụ mgbe ị na-eji ngwaahịa a.
P264: saa anụ ahụ nke ọma mgbe ejirichara ya.
P301 + P310 + P330: Ọ BỤRỤ NA EKWU: Kpọọ CENTER POISON/Dọkịta ozugbo.Sachaa ọnụ.
P405: Akpọchiri ụlọ ahịa.
Iwu ndị emetụtara
Ozi njem:
Nọmba UN (DOT-AIR) UN2811
Klas (DOT-AIR) 6.1
Otu nkwakọ ngwaahịa (TCI-A) III
Nọmba HS 2933.29.9000
Brimonidine Tartrate (CAS: 70359-46-5) bụ onye na-egbochi α2-receptor nke ukwuu, nke US Company Allergan mepụtara nke ọma, nke bụ ọgwụ anya.Ọ nwere ike ibelata nrụgide intraocular (IOP).Brimonidine Tartrate ophthalmic solution saling n'ahịa bụ ụdị Brimonidine Tartrate, nke bụ ezigbo ọgwụ na-ebelata IOP maka glaucoma na-adịghị ala ala na ọgwụgwọ ọbara mgbali elu nke ndị ọrịa, kamakwa maka ọkwa argon laser IOP.Brimonidine Tartrate ophthalmic solution nwere usoro eji eme ihe site na ibelata mmepụta ihe ọchị na ịba ụba pigmenti oyi akwa nke ebumnuche ọgwụgwọ Scleral mmiri.Mgbe ịdaba n'ime anya, mmetụta ahụ dị ngwa ngwa, ọ pụkwara iru elu mgbe ị na-eji ihe ruru 2h, na oge dị irè nwere ike ịnọgide na-enwe 12h.Ọbara nwere ike ịchọpụta naanị akara ọgwụ.Ngwaahịa a nwere metabolism nke mbụ na imeju, yana metabolites na-apụ na mmamịrị site na akụrụ.A naghị emetụta nnabata usoro na nkesa, na ndị agadi anaghị achọ mmezi dose.Brimonidine Tartrate ophthalmic ngwọta ma e jiri ya tụnyere ndị ọzọ α-blockers, abụba-soluble dị ntakịrị, ebe ọ naghị adị mfe ịgafe ihe mgbochi ụbụrụ ọbara na ọ dịghị emepụta nkwụsịtụ, hypotension na ndị ọzọ yiri clonidine Central mmeghachi omume ọjọọ.Brimonidine Tartrate Ophthalmic Solution na-ahọrọ nke ọma maka ndị na-anabata α2-adrenergic, na α2 / α1 ruru nke nnabata nnabata karịrị ugboro 1000.Mmetụta nke ndị na-anabata alfa 2 nwere ike ime ka nrụgide intraocular dị ala.Na ọrụ nke ndị na-anabata alfa 1 nwere ike ibute mkpụkọ vaskụla, mwepu nku anya ma ọ bụ mbelata na mgbasa nke nwa akwụkwọ ahụ.Ngwa ngwa ngwa nke ngwaahịa a agaghị eme ngwa ngwa.Na mgbakwunye, ma e jiri ya tụnyere β-blockers, Brimonidine Tartrate anya na-adaba maka obere mmetụta obi, ọ nweghị mmetụta na ọrụ ngụgụ, ya mere ọ dị mma maka ndị nwere nkwarụ β-blockers.Ọzọkwa, mgbe ejiri naanị β-blocker, ọ nweghị ike nweta ebumnuche ọgwụgwọ, ma ị nwere ike ịbawanye FDA n'otu oge.
